Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
AARTI DRUGS 527.35 0.22% 525.05 -0.52%
 More Info 
AJANTA PHARMA 995.20 2.63% 997.10 2.87%
 More Info 
ALEMBIC PHARMA 519.55 -0.84% 520.35 -0.91%
 More Info 
BIOCON LTD 592.55 1.81% 591.60 1.55%
 More Info 
CADILA HEALTHCARE 359.50 2.70% 360.15 2.97%
 More Info 
CIPLA 637.55 2.60% 637.45 2.66%
 More Info 
DIVIS LABORATORIES 1,074.20 0.70% 1,074.65 0.43%
 More Info 
GLENMARK PHARMA 563.10 2.08% 564.00 2.18%
 More Info 
INDOCO REMEDIES 178.50 3.42% 179.40 4.30%
 More Info 
IPCA LABS 741.95 -0.52% 743.75 -0.61%
 More Info 
J.B.CHEMICALS 258.95 1.91% 260.55 2.20%
 More Info 
LUPIN LTD 828.25 1.20% 827.40 1.13%
 More Info 
NATCO PHARMA 786.00 -0.52% 789.20 0.01%
 More Info 
NIFTY 50 Not Listed 11,008.05 0.65%
 More Info 
ORCHID PHARMA LTD 7.18 -2.97% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 220.20 1.62% 222.15 2.44%
 More Info 
PIRAMAL ENTERPRISES 2,525.35 0.18% 2,531.40 0.35%
 More Info 
S&P BSE SENSEX 36,519.96 0.54% Not Listed
 More Info 
STRIDES SHASUN LTD 360.30 1.91% 360.00 1.84%
 More Info 
SUN PHARMA 548.80 2.97% 548.65 2.75%
 More Info 
TORRENT PHARMA 1,451.80 1.27% 1,449.60 1.05%
 More Info 
WOCKHARDT LTD. 594.15 0.23% 593.20 -0.01%
 More Info 

BSE prices: July 17, 2018  (Close)    NSE prices: July 17, 2018  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,926.1 (up 1.6%). The index is down 4.2% over the last 30 days. And over the last 1 year, it has lost 10.7%.

Within the Indian Pharma sector, the top gainers were INDOCO REMEDIES (up 3.4%) and SUN PHARMA (up 3.0%). On the other hand, ORCHID PHARMA LTD (down 3.0%) and ALEMBIC PHARMA (down 0.8%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 11,008.1 (up 0.7%).

Today's Market

Sensex Surges 200 Points; Energy Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day in green.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5%

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 10.7%

Jun 1, 2018 | Updated on Jun 1, 2018

For the quarter ended March 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 10.7% YoY). Sales on the other hand came in at Rs 17 bn (up 20.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

The Real Truth About India's FDI, Beyond WhatsApp(Vivek Kaul's Diary)

Jul 4, 2018

The FDI numbers do not look very impressive once we adjust for repatriations as well as the overall growth in the economy.

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jul 17, 2018 (Close)